Wei Li

Wei Li

Auto-generated profile, based on publicly available information

Wei Li

Experimental Research Center for Medical and Psychological Sciences, School of Psychology, Third Military Medical University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2025 in ALPHA PSYCHIATRY
Verified
Journal Article
Open access
XLXuerong Liu
Xuerong Liu
WLWei Li
Wei Li
JLJingyu Lei
Jingyu Lei
XHXiaodi Han
Xiaodi Han
QZQiongzhi Zhang
Qiongzhi Zhang
ZFZhengzhi Feng
Zhengzhi Feng
Objective: To tailor culturally sensitive interventional strategies for safeguarding adolescents’ mental health, this study investigated the role of perceived parental involvement in predicting depressive symptoms among Chinese adolescents, considering family socioeconomic status (SES). Methods: A cluster convenience sampling method recruited 21,818 participants from 48 middle schools across 29 provinces in China. The perceived parental involvement (PPI) Scale and the Chinese version of the center for epidemiologic studies depression scale (CES-D) assessed parental involvement and depressive symptoms, respectively. Data analysis employed linear mixed-effect models (LMM) and latent profile analysis (LPA). Results: The results indicated that 35.26% of adolescents exhibited subclinical depressive symptoms. LMM analysis revealed that higher perceived parental involvement scores, particularly emotional involvement, significantly predicted lower CES-D scores (β = –0.45, p < 0.001). LPA identified three distinct family factors profiles, with the “High SES-High PPI” group showing the lowest depression scores. Conclusion: The findings underscore the protective benefits of perceived parental involvement, especially emotional support, in mitigating depressive symptoms among adolescents. Specifically, adolescents from families with both high SES and high parental involvement exhibited the lowest levels of depressive symptoms, suggesting that interventions should focus on enhancing emotional support and addressing socioeconomic disparities to effectively reduce adolescent depression.

4 September 2024 in OSF Preprints
Verified
Preprint
Open access
ZCZhiyi Chen
Zhiyi Chen
WLWei Li
Wei Li
ZLZhicheng Lin
Zhicheng Lin
The rapid development of medical artificial intelligence (AI) in clinical settings has raised critical debates about their real-world generalizability, yet evidence remains sporadic. Here, we systematically investigate which patients benefit from mature medical AI models during real-world deployments. Using an end-to-end NLP model, we synthesized data from 296,499 scientific publications spanning from January 1998 to January 2024, focusing on 4,361 studies that reported characteristics of mature medical AI models. These models were primarily used in a few specialties (e.g., oncology). Analyzing patient demographics and model performance from 1,590,612 patients, we uncovered a striking imbalance: 97.7% of patients benefiting from AI diagnostics were either Asian or White, predominantly from China (40.8%) and the US (12.4%), showing statistically significant geospatial, economic and racial inequalities (Dagum-Gini coefficient = 0.81, 0.87, 0.97, p < .05), particularly to Black populations in less economic developing countries (LEDC). Notably, almost all these patients (98.6%) were diagnosed using AI models developed with demographic samples similar to their own, showing superior performance compared to human diagnoses (85.9% vs. 77.9% accuracy, p < .001). However, when these AI models were applied outside of the training demographic groups, their effectiveness did not significantly surpass that of human practitioners. These results suggest a failure of generalization in real-world clinical applications, and highlight a troubling exclusivity/inequality in the benefits of mature medical AI models, which are largely limited to underrepresented populations, especially in Black patients from third-nation countries.

24 May 2025 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
QZQianyu Zhang
Qianyu Zhang
LRLi Ran
Li Ran
WLWei Li
Wei Li
XLXuerong Liu
Xuerong Liu
JGJie Gong
Jie Gong
JZJing-Xuan Zhang
Jing-Xuan Zhang
Depression has emerged as a leading contribution of the global mental health burden, particularly among underrepresented adolescents. Despite the World Health Organization’s promotion of primary mental healthcare as a critical solution, its real-world effectiveness in low- and middle-income countries remains debated due to high costs and insufficient follow-up. This study aimed to explore the impact of primary mental healthcare on the core symptoms of adolescent depression using network analysis, while examining the influence of demographic factors such as gender, age, and family support, to identify more precise and targeted healthcare strategies, improving its effectiveness. A citywide, multi-center, longitudinal cohort study was conducted in Nanchong, Sichuan Province, China, involving 73,750 adolescents (34,606 girls and 39,144 boys) with median age of 14.00 years old. The Comprehensive Primary Healthcare for Adolescents Program (CPHG) involved two rounds of psychological screening and early intervention. Depressive symptoms were assessed using the Center for Epidemiological Studies Depression Scale (CES-D). Network analysis was employed to map the interrelations between depressive symptoms and evaluate the healthcare’s impact. The CPHG program significantly reduced CES-D median scores from 6.00 to 2.00 (p < 0.001). Network analysis revealed changes in the structure and centrality of depressive symptoms post-intervention, with specific symptoms such as sadness (C18) showing consistent reductions across subgroups. Gender disparities were evident, with female adolescents exhibiting stronger symptom interconnectivity. Junior high school students also demonstrated a more robust symptom network compared to senior high school students. Adolescents living in social welfare institutions exhibited higher global expected influence of depressive symptoms than those living with both parents. Primary mental healthcare effectively modifies the network structure of depressive symptoms in adolescents, with specific symptoms like sadness being critical targets. Gender and grade-level differences highlight the need for tailored mental healthcare strategies. The findings underscore the importance of addressing both core and peripheral symptoms to enhance treatment efficacy and reduce the severity and recurrence of depression among underrepresented adolescents.

30 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
WLWei Li
Wei Li
XLXuerong Liu
Xuerong Liu
QZQianyu Zhang
Qianyu Zhang
LSLiping Shi
Liping Shi
JZJing-Xuan Zhang
Jing-Xuan Zhang
ZCZhiyi Chen
Zhiyi Chen
Background: The spurious and unavailable data/code sharing actions are crashing open medical sciences. In this study, we aimed to illustrate how high-profile medical journals are practically carried out their sharing policies and what questionable practices regarding data/code sharing are conducted by authors. Methods: In this study, we appraised the policy on data/code availability of high-profile medical journals ranked at Q1 according to Clarivate Journal Citation Report (JCR 2021). Furthermore, we recruited post-publications published by four leading medical journals (i.e., The BMJ, JAMA, NEJM and The Lancet) from the issuing of data/code availability policy to December 2022 for the questionable practices in data/code sharing. The appraisal of papers was conducted by the Data/code Availability Statement Practice Evaluation Tool (DANCE), developed by systematically integrating mainstreaming open data/code guidelines. Findings: We found that less than one-tenth journals (9.1%) mandated authors to share data/code, with an available statement. Among these journals, 70.6% (61.2%) did not consider censoring (restricting) spurious/invalid data/code sharing in publications. Furthermore, though journal impact factor could predict policy stringency on “offering availability statements” ( p < .001), it failed to predict ones in “sharing data/code” ( p = .73). For publications, even in leading medical journals (i.e., The BMJ, JAMA, NEJM and The Lancet), only 0.5% of the papers (16/3,191) fully complied with their public sharing statements for reaching reproducibility. Lack of availability statement, declining data/code sharing without reasons, and invalid repositories were leading questionable practices conducted by authors. Interpretation: We clarified specific questionable actions of implementing and practicing the sharing policy both in journal and papers, which should be addressed not only by the supportive publication ecosystem but also by crediting authors for taking responsibility and maintaining scientific integrity in data/code sharing. Funding: No funding.

29 July 2025 in PNAS Nexus
Verified
Journal Article
Open access
XLXuerong Liu
Xuerong Liu
WLWei Li
Wei Li
QZQianyu Zhang
Qianyu Zhang
JLJingyu Lei
Jingyu Lei
XHXiaodi Han
Xiaodi Han
ZCZhiyi Chen
Zhiyi Chen
The fast-tracked publication of coronavirus disease 2019 (COVID-19)-related meta-analytic evidence has undeniably facilitated rapid public health policymaking; however, concerns are mounting that this publication policy may compromise research quality and scientific integrity. To investigate this, we conducted a meta-research study systematically evaluating risk of bias (ROB), transparency, and reproducibility in pandemic-era meta-analyses synthesizing COVID-19-derived mental health problem epidemics. From 98 identified studies—including data from 18.6 million individuals across 94 countries—we observed significant ROBs in publication, with one new meta-analysis published approximately every 5 days at peak output. Despite apparent sample diversity, nearly half of participants were from China, and only 8.9% originated from less economically developed countries. Of these meta-analyses, a substantial proportion (70.6%) showed discrepancies between Preferred Reporting Items for Systematic Reviews and Meta-Analyses–guided reporting and actual research conducts, while 57.1% exhibited high methodological ROBs due to insufficient data sources and lack of sensitivity analysis. Alarmingly, none achieved full computational reproducibility, and fewer than one-fifth were fully replicable. Furthermore, neither publication in high-impact journals, citation performance, nor fast-track publication mode correlated with lower ROBs that we identified above. To address these limitations, we re-estimated global COVID-19-derived mental health epidemics using their individual participant data after minimizing identified ROBs. Our recalibrated meta-analytic findings provide more reliable benchmarks for understanding the pandemic's mental health impact. This study demonstrated that rigorous methodology and scientific integrity must remain central priorities—even under urgent, crisis-driven conditions—establishing a foundation for transparent, reproducible, and unbiased global mental health surveillance during public health emergencies.

1 January 2025 in Depression and Anxiety
Verified
Journal Article
Open access
WLWei Li
Wei Li
XLXue-Rong Liu
Xue-Rong Liu
QZQianyu Zhang
Qianyu Zhang
LXLei Xia
Lei Xia
YLYanyan Li
Yanyan Li
ZCZhiyi Chen
Zhiyi Chen
Background: Given the historically high incidence of depressive disorders among children/adolescents, efforts to implement universally accessible primary psychological health care policies have been undertaken globally. However, the practical implementation and its association with depression risk reduction remain uncertain, particularly for underprivileged children/adolescents who are underrepresented in the current system. Methods: A large‐scale cohort of underprivileged children/adolescent population aged 6–18 was enrolled ( n = 290,239). Subgroups with specific underprivileged conditions were identified, including de facto unattended children/adolescents (dfUCA), orphans, and children/adolescents facing especially difficult circumstances, “left‐behind” and “single‐parent” children/adolescents. A subgroup of matched typically developing individuals was also included. These subgroups underwent longitudinal assessments for the incidence of identifying depression on Oct 30, 2022 (baseline, before implementing primary psychological health care policy), May 21, 2023 (half year follow‐up), and Oct 29, 2023 (1‐year follow‐up), respectively. Results: At baseline, nearly twice as high incidence of depression was found in the underprivileged group (13.9%, 95% confidence interval [CI]: 13.7–14.1) as in the control group (7.5%, 7.2–7.7). After the implementation of the primary psychological policy, at the half year follow‐up, a notable decrease in the incidence of depression was observed in both the underprivileged group (5.8%, relative risk reduction (RRR) = 51.6%, 51.5–51.7, p < 0.001) and the typically developing group (4.0%, RRR = 34.5%, 27.9–41.0, p < 0.001), particularly among orphan girls aged 12–18. The observed changes in depression incidence across all underprivileged populations were statistically noninferior compared to the typically developing group (all p < 0.001). At the 1‐year follow‐up, the observed benefits were consistent across all subgroups when compared to baseline. The average expenditure per child/adolescent was $1.6 in implementing such a health care policy. Conclusions: Implementing the primary psychological health care policy is associated with a reduction in the citywide risk of depression among underprivileged children/adolescents in low–middle‐income areas.